Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
European Journal of Haematology|February 14, 2004
Long-term follow up of patients with multiple myeloma after high-dose chemotherapy and allogeneic stem cell transplantationWerner Rabitsch, Erika Prinz, Jutta Ackermann, et al.
Transfusion|June 27, 2002
Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3Felix Keil, Fariborz Elahi, Hildegard T Greinix, et al.
Investigative Radiology|August 3, 2011
Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2* relaxation effectsJens-Peter Kühn, Matthias Evert, Nele Friedrich, et al.
Transplantation|February 23, 2018
Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant RecipientsDaniel Zecher, Christian Bach, Adrian Preiss, et al.
International Journal of Molecular Sciences|March 28, 2026
The Novel HSF1 Inhibitor NXP800 Exhibits Robust Antitumor Activity in Hepatocellular CarcinomaSara M Steinmann, Melania Lazzari, Augustinus Kleinle, et al.
The Journal of Clinical Investigation|July 17, 2012
Cholangiocarcinomas can originate from hepatocytes in miceBiao Fan, Yann Malato, Diego F Calvisi, et al.
Radiology|August 28, 2012
Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging resultsJens-Peter Kühn, Diego Hernando, Alejandro Muñoz del Rio, et al.
Oncotarget|May 8, 2018
DWI - histology: a possible means of determining degree of liver fibrosis?Niklas Verloh, Kirsten Utpatel, Michael Haimerl, et al.
Anticancer Research|October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3Ewald Wöll, Josef Thaler, Felix Keil, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2016
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)Michael A Fridrik, Ulrich Jaeger, Andreas Petzer, et al.
Pageof 26